Iridex (IRIX) Gross Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -112.00 |
| Sep 27, 2025 | -936.00 |
| Jun 28, 2025 | -419.00 |
| Mar 29, 2025 | -92.00 |
| Dec 28, 2024 | 276.00 |
| Sep 28, 2024 | -283.00 |
| Jun 29, 2024 | -298.00 |
| Mar 30, 2024 | -227.00 |
| Dec 30, 2023 | -182.00 |
| Sep 30, 2023 | 332.00 |
| Jul 1, 2023 | 30.00 |
| Apr 1, 2023 | 208.00 |
| Dec 31, 2022 | 2,267.00 |
| Oct 1, 2022 | 389.00 |
| Jul 2, 2022 | 62.00 |
| Apr 2, 2022 | 206.00 |
| Jan 1, 2022 | -135.00 |
| Oct 2, 2021 | 23.00 |
| Jul 3, 2021 | -266.00 |
| Apr 3, 2021 | -310.00 |
| Sep 26, 2020 | -781.00 |
| Jun 27, 2020 | -800.00 |
| Mar 28, 2020 | -670.00 |
| Sep 28, 2019 | -1,073.00 |
| Jun 29, 2019 | -642.00 |
| Mar 30, 2019 | -876.00 |
| Dec 29, 2018 | -756.00 |
| Sep 29, 2018 | -917.00 |
| Jun 30, 2018 | -724.00 |
| Mar 31, 2018 | -609.00 |
| Dec 30, 2017 | -2,582.00 |
| Sep 30, 2017 | -938.00 |
| Jul 1, 2017 | -374.00 |
| Apr 1, 2017 | -540.00 |
| Dec 31, 2016 | 2,853.00 |
| Oct 1, 2016 | -1,210.00 |
| Jul 2, 2016 | 299.00 |
| Apr 2, 2016 | -543.00 |
| Oct 3, 2015 | -20,328.00 |
| Jul 4, 2015 | -1,143.00 |